Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176480 | SCV000228144 | uncertain significance | not provided | 2014-09-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001257067 | SCV000751555 | likely benign | Duchenne muscular dystrophy | 2024-08-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004537401 | SCV004115265 | uncertain significance | DMD-related disorder | 2023-03-30 | criteria provided, single submitter | clinical testing | The DMD c.3269A>T variant is predicted to result in the amino acid substitution p.Gln1090Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.021% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/X-32482710-T-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Natera, |
RCV001832009 | SCV002085472 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2020-04-29 | no assertion criteria provided | clinical testing |